Boston, MA 04/01/2014 (wallstreetpr) – morning trading session, moving up by highs of $18.65%. The huge gains comes at the back of Tetralogic announcing that data published in the April issue of Molecular Cancer Therapeutics, further advances the company’s lead SMAC-Mimetic Birianapant.
The product is currently under Phase 1 and Phase II clinical trials in a bid of trying to find its Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)’s stock has been one of the top gainers in effectiveness in the treatment of hematological malignancies as well as Solid Tumors.
The company has already been impressed with the results of the studies which continue to support a combination of Birianapant for multiple chemotherapies. Data from the studies indicate that Birianapant has the potential to be used in a wide variety of Cancers.
Tetralogic Pharmaceuticals CEO Wins an Award
Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) in other news has also confirmed that it’s President and Chief Executive Officer J. Kevin Buchi will attend the 13th Annual Needham Healthcare Conference to be held on April 8, 2014 and is expected to make a presentation.
Tetralogic’s CEO Kevin Buchi was recently recognized for his achievements and contribution towards the pharmaceutical industry consequently winning the CEO of the year award, awarded byPennsylvania Bio. The award recognizes CEO’s who have shown splendid and visionary leadership achievement throughout the year while showing commitments to patients and the industry.
Sungy Mobile Ltd (NASDAQ:GOMO) Continues to Surge in the market
Sungy Mobile Ltd (NASDAQ:GOMO) best known for its Product GO launcher EX, continues to surge in the market at the back of huge traded volumes as the company continues to reap on its recently released financial results. The company’s shares have already gained by highs of 18.22% in Intraday trading session and looks set to continue rallying.
The company’s mobile product and services continue to perform well online and for the first time in the company’s history, accounted 50% of the company’s total revenue. The accomplishment in this case highlighted Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)’s improved user experience. The quality of user experience has already driven the company’s ability to expand its broadband app’s adaption. Looking ahead, Sungy Mobile plans to expand its user base through the strengthening of its Go platform.